QuinStreet, Inc (QNST)
$10.10 0.29 (2.79%)
18:20 EDT QNST Stock Quote Delayed 30 Minutes
Previous Close $10.10
Market Cap 476.05M
PE Ratio 56.11
Volume (Avg. Vol.) 269,900
Day's Range 10.08 - 10.53
52-Week Range 5.76 - 17.13
Dividend & Yield N/A (N/A)
QNST Stock Predictions, Articles, and QuinStreet, Inc News
- From InvestorPlace
- From the Web
The economy is picking up steam, and so are these stocks. If you're looking for growth stocks, these belong on your shortlist.
More analyst coverage over the last few weeks might translate into solid price appreciation for these stocks. Compare Brokers....
Cash indicates a company’s true financial health. It is the key to its existence, development and success. Compare Brokers....
Six stocks with a handsome net profit margin that can contribute to making a winning portfolio. Compare Brokers....
Cash is the lifeblood of any business. It offers strength, vitality and flexibility to make investment decisions, and the fuel to run the growth engine. Compare....
One of the major advantages that small-caps hold over their large-cap peers is their strong domestic focus. Compare Brokers....
Here are five stocks with spectacular net profit margin that investors can count on for stellar returns. Compare Brokers....
3 Stocks to Watch on Thursday: American Water Works Company Inc (AWK), QuinStreet Inc (QNST) and Zumiez Inc. (ZUMZ)
American Water Works (AWK), QuinStreet (QNST) and Zumiez (ZUMZ) all made headlines over the weekend over quarterly and monthly results, plus an acquisition.
Technology stocks like Harvard Bioscience (HBIO) and TechTarget, Inc. (TTGT), among others, have great growth potential. Compare Brokers....
The technology sector has shown immense upside potential this month even amid market turmoil. Compare Brokers...
From Seeking Alpha
From Seeking Alpha
Corvus Pharmaceuticals (NASDAQ:CRVS) +103% on launch immunotherapy study for COVID-19.Annovis Bio (NYSEMKT:ANVS) +85% on launch mid-stage study of lead drug in Alzheimer's and Parkinson's.Novavax (NASDAQ:NVAX) +35% after scoring $1.6B in funding from Operation Warp Speed.Hepion Pharmaceuticals (NASDAQ:HEPA) +23% on preclinical data supporting novel two-pronged approach to treating COVID-19 with CRV431.Vivint Solar (NYSE:VSLR) +21% on being acquired by Sunrun.Endo International plc (NASDAQ:ENDP) +19% as FDA approves Endo's Qwo for treatment of cellulite.AgEagle Aerial Systems (NYSEMKT:UAVS) +19%.BELLUS Health (NASDAQ:BLU) +15%.Otonomy (NASDAQ:OTIC) +14% on positive data on tinnitus candidate and Otividex.Future FinTech (NASDAQ:FTFT) +14% on Q1 results.ObsEva SA (NASDAQ:OBSV) +12%.Sunrun (NASDAQ:RUN) +11% on acquiring Vivint Solar.Livongo Health (NASDAQ:LVGO) +10% sees Q2 revenue as high as $87MVaxart (NASDAQ:VXRT) +9%.MYOS RENS Technology (NASDAQ:MYOS) +13% on publication of a study that evaluated the impact of Fortetropin on the rate of muscle protein synthesis in older adults.Northern Dynasty Minerals (NYSEMKT:NAK) +9% on Pebble partnership.Ayro (NASDAQ:AYRO) +7%.CTI BioPharma (NASDAQ:CTIC) +7%.Beasley Broadcast (NASDAQ:BBGI) +5%.
Navellier RatingsPowered by Portfolio Grader